US Securities and Exchange Commission announced today that it is dropping an insider‑trading lawsuit that had been filed against a former healthcare executive. This decision marks a significant shift in the SEC’s enforcement approach, as the agency moves away from pursuing the case.

The lawsuit was originally brought after the executive was found guilty in a related criminal case for engaging in insider trading. The SEC had cited evidence that the executive had used confidential information to benefit personal trading activities.

The executive was later pardoned by President Donald Trump, gitar which has influenced the SEC’s decision to abandon the civil action.

The SEC’s ruling indicates that the agency may prioritize cases where enforcement can yield stronger regulatory outcomes. The decision also reflects the broader legal context surrounding presidential pardons and securities law compliance. This move may signal a recalibration of the SEC’s litigation strategy in similar circumstances.